Found 39 Enz. Inhib. hit(s) with all data for entry = 6346 TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 0.260nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 0.5nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 0.5nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 0.600nM IC50: 1nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 0.650nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 0.900nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 0.980nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1.10nM IC50: 1.20nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1.10nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1.30nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1.30nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1.37nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1.40nM IC50: 6.70nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1.60nM IC50: 25.6nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1.60nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1.80nM IC50: 3.90nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 1.80nM IC50: 42nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 2.20nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 2.5nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 2.80nM IC50: 12.8nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 2.90nM IC50: 42.6nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 3nM IC50: 1nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 3.5nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 4.60nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 5.40nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 11.7nM IC50: 5.40nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 12nM IC50: 18.9nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 16.5nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 49.2nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(3) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataKi: 62.1nMAssay Description:Methods for performing in vitro dopamine receptor binding studies are described in Huang et al. J. Med. Chem. 44:1815-1826 (2001) and Luedtke et al. ...More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataIC50: 15.8nMT: 2°CAssay Description:To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), ...More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataIC50: 22.9nMT: 2°CAssay Description:To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), ...More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataIC50: 41nMT: 2°CAssay Description:To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), ...More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataIC50: 88.3nMT: 2°CAssay Description:To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), ...More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataIC50: 175nMT: 2°CAssay Description:To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), ...More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataIC50: 179nMT: 2°CAssay Description:To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), ...More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataIC50: 368nMT: 2°CAssay Description:To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), ...More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Homo sapiens (Human))
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services
US Patent
Affinity DataIC50: 1.30E+3nMT: 2°CAssay Description:To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), ...More data for this Ligand-Target Pair
